Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008
- PMID: 21293325
Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008
Abstract
Background: Hypertension is a modifiable risk factor for cardiovascular disease. It affects one in three adults in the United States and contributes to one out of every seven deaths and nearly half of all cardiovascular disease-related deaths in the United States.
Methods: CDC analyzed data from the National Health and Nutrition Examination Survey (NHANES) on the prevalence, treatment, and control of hypertension among U.S. adults aged ≥18 years. Hypertension was defined as an average blood pressure ≥140/90 mmHg or the current use of blood pressure-lowering medication. Control of hypertension was reported as an average treated systolic/diastolic blood pressure <140/90 mmHg. Multivariate analysis was performed to assess changes in prevalence of hypertension, use of pharmacologic treatment, and control of blood pressure between the 1999-2002 and 2005-2008 survey cycles.
Results: During 2005-2008, approximately 68 million (31%) U.S. adults aged ≥18 years had hypertension, and this prevalence has shown no improvement in the past decade. Of these adults, 48 million (70%) were receiving pharmacologic treatment and 31 million (46%) had their condition controlled. Although 86% of adults with uncontrolled blood pressure had medical insurance, the prevalence of blood pressure control among adults with hypertension was especially low among participants who did not have a usual source of medical care (12%), received medical care less than twice in the previous year (21%), or did not have health insurance (29%). Control prevalence also was low among young adults (31%) and Mexican Americans (37%). Although the prevalence of hypertension did not change from 1999-2002 to 2005-2008, significant increases were observed in the prevalence of treatment and control.
Conclusions: Hypertension affects millions of persons in the United States, and less than half of those with hypertension have their condition controlled. Prevalence of treatment and control are even lower among persons who do not have a usual source of medical care, those who are not receiving regular medical care, and those who do not have health insurance.
Implications for public health practice: To improve blood pressure control in the United States, a comprehensive approach is needed that involves policy and system changes to improve health-care access, quality of preventive care, and patient adherence to treatment. Nearly 90% of persons with uncontrolled hypertension have health insurance, indicating a need for health-care system improvements. Health-care system improvements, including use of electronic health records with registry and clinical decision support functions, could facilitate better treatment and follow-up management, and improve patient-physician interaction. Allied health professionals (e.g., nurses, dietitians, health educators and pharmacists) could help increase patient adherence to medications. Patient adoption of healthy behaviors could improve their blood pressure control. Reducing dietary intake of salt would greatly support prevention and control of hypertension; a 32% decrease in average daily consumption, from 3,400 mg to 2,300 mg, could reduce hypertension by as many as 11 million cases. Further reductions in sodium intake to 1,500 mg/day could reduce hypertension by 16.4 million cases.
Similar articles
-
Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):109-14. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21293326
-
Vital signs: awareness and treatment of uncontrolled hypertension among adults--United States, 2003-2010.MMWR Morb Mortal Wkly Rep. 2012 Sep 7;61:703-9. MMWR Morb Mortal Wkly Rep. 2012. PMID: 22951452
-
Surveillance of certain health behaviors and conditions among states and selected local areas --- Behavioral Risk Factor Surveillance System, United States, 2009.MMWR Surveill Summ. 2011 Aug 19;60(9):1-250. MMWR Surveill Summ. 2011. PMID: 21849967
-
Treatment of hypertension in chronic kidney disease.Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016. Semin Nephrol. 2005. PMID: 16298269 Review.
-
What is the prevalence of resistant hypertension in the United States?Curr Opin Cardiol. 2012 Jul;27(4):386-91. doi: 10.1097/HCO.0b013e328353ad6e. Curr Opin Cardiol. 2012. PMID: 22596184 Review.
Cited by
-
Secular Trends in Prescription Patterns of Single-Pill Combinations of an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Plus a Thiazide Diuretic for Hypertensive Patients in Taiwan.Acta Cardiol Sin. 2013 Jan;29(1):49-55. Acta Cardiol Sin. 2013. PMID: 27122684 Free PMC article.
-
Current perspectives on combination therapy in the management of hypertension.Integr Blood Press Control. 2013 Jun 17;6:69-78. doi: 10.2147/IBPC.S33985. Print 2013. Integr Blood Press Control. 2013. PMID: 23837009 Free PMC article.
-
The role of home blood pressure telemonitoring in managing hypertensive populations.Curr Hypertens Rep. 2013 Aug;15(4):346-55. doi: 10.1007/s11906-013-0351-6. Curr Hypertens Rep. 2013. PMID: 23625207 Free PMC article. Review.
-
Contraceptive methods and informed consent among women receiving medications with potential for adverse fetal effects: a Washington, Wyoming, Alaska, Montana, Idaho (WWAMI) region study.J Am Board Fam Med. 2012 Sep-Oct;25(5):661-8. doi: 10.3122/jabfm.2012.05.120056. J Am Board Fam Med. 2012. PMID: 22956701 Free PMC article.
-
Self-reported hypertension and use of antihypertensive medication among adults - United States, 2005-2009.MMWR Morb Mortal Wkly Rep. 2013 Apr 5;62(13):237-44. MMWR Morb Mortal Wkly Rep. 2013. PMID: 23552224 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous